Mutations in Epigenetic Modifiers in Myeloid Malignancies and the Prospect of Novel Epigenetic-Targeted Therapy
In the recent years, the discovery of a series of mutations in patients with myeloid malignancies has provided insight into the pathogenesis of myelodysplastic syndromes (MDSs), myeloproliferative neoplasms (MPNs), and acute myeloid leukemia (AML). Among these alterations have been mutations in gene...
Main Authors: | Amir T. Fathi, Omar Abdel-Wahab |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2012/469592 |
Similar Items
The Prospects of Epigenetics in Neuroscience
by: Hamid Mostafavi Abdolmaleky
Published: (2011-09-01)
by: Hamid Mostafavi Abdolmaleky
Published: (2011-09-01)
Similar Items
-
Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors
by: Johanna S. Ungerstedt
Published: (2018-10-01) -
Insights into novel emerging epigenetic drugs in myeloid malignancies
by: Namrata S. Chandhok, et al.
Published: (2019-08-01) -
The Impact of Epigenetic Modifications in Myeloid Malignancies
by: Deirdra Venney, et al.
Published: (2021-05-01) -
Epigenetic Gene Mutations Impact on Outcome in Acute Myeloid Leukaemia
by: Christine S. Young, et al.
Published: (2015-06-01) -
Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia
by: Bettina Wingelhofer, et al.
Published: (2019-09-01)